Deep Learning and Multi-Omics Integration in Liver Disease Detection

Deep learning, when combined with multi-omics data, represents a cutting-edge approach for early and precise detection of liver disease. By integrating genomics, transcriptomics, proteomics, and metabolomics with imaging modalities such as MRI or ultrasound elastography, AI models can uncover complex molecular and structural signatures of liver fibrosis that are undetectable by conventional methods. Convolutional neural networks (CNNs) and other deep learning architectures can analyze high-dimensional datasets, identifying subtle correlations between circulating biomarkers such as fibrosis-associated microRNAs or collagen fragments and tissue-level radiomic features. This integrated approach enhances predictive accuracy, enabling detection of subclinical fibrosis, patient stratification for targeted therapy, and the potential development of personalized treatment strategies. Multi-omics integration therefore positions AI not only as a diagnostic tool but also as a platform for precision hepatology research.